Peter G Stock
Affiliation: University of California
- Evolving clinical strategies for transplantation in the HIV-positive recipientPeter G Stock
Department of Surgery, University of California San Francisco, San Francisco, CA 94143, USA
Transplantation 84:563-71. 2007..This overview will describe the evolving clinical strategies that have resulted in good outcomes after solid organ transplantation in the HIV-positive recipient...
- The year in review--ATC 2002Peter G Stock
Department of Surgery, Division of Transplantation, University of California San Francisco, San Francisco, CA 94143 0780, USA
Am J Transplant 3:373-80. 2003....
- Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy studyPeter G Stock
Department of Surgery, Division of Transplantation, University of California, San Francisco, California 94143 0780, USA
Transplantation 76:370-5. 2003....
- Beta-cell replacement for type I diabetesPeter G Stock
Department of Surgery, Division of Transplantation, University of California, San Francisco, San Francisco, California 94143, USA
Annu Rev Med 55:133-56. 2004..Widespread application of islet transplantation will depend on further improvements in selective immunosuppression, development of immunologic tolerance, and finding new sources of beta cells...
- Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfectionNorah A Terrault
University of California San Francisco, 513 Parnassus Avenue, San Francisco, CA 94143, USA
Liver Transpl 18:716-26. 2012..Our results indicate that HCV per se is not a contraindication to LT in HIV patients, but recipient and donor selection and the management of acute rejection strongly influence outcomes...
- Outcomes of kidney transplantation in HIV-infected recipientsPeter G Stock
University of California, San Francisco, San Francisco, CA 94143 0116, USA
N Engl J Med 363:2004-14. 2010..The outcomes of kidney transplantation and immunosuppression in people infected with human immunodeficiency virus (HIV) are incompletely understood...
- Cyclosporine pharmacokinetics and dosing modifications in human immunodeficiency virus-infected liver and kidney transplant recipientsLynda Frassetto
Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA
Transplantation 80:13-7. 2005....
- Surgical complications in 275 HIV-infected liver and/or kidney transplantation recipientsJack Harbell
University of California, San Francisco, San Francisco, CA 94143 0470, USA
Surgery 152:376-81. 2012..In this report, we examine the surgical safety and complications (SC) among 125 liver (L) and 150 kidney (K) HIV+ transplantation (TX) recipients in a prospective nonrandomized U.S. multicenter trial...
- BKV in simultaneous pancreas-kidney transplant recipients: a leading cause of renal graft loss in first 2 years post-transplantGerald S Lipshutz
University of California, Los Angeles, Department of Surgery, Los Angeles, CA, USA
Am J Transplant 5:366-73. 2005..The pancreas, however, is spared from evidence of infection, and no pancreatic rejection occurred when immunosuppression was decreased...
- HLA-DR matching in organ allocation: balance between waiting time and rejection in pediatric kidney transplantationLan T Vu
Department of Surgery, University of California at San Francisco, San Francisco, CA 94143 0780, USA
Arch Surg 146:824-9. 2011....
- Successful clinical islet isolation using a GMP-manufactured collagenase and neutral proteaseGregory L Szot
Department of Internal Medicine, Diabetes Center, University of California San Francisco, San Francisco, CA, USA
Transplantation 88:753-6. 2009..Here, we describe the factors that we consider most important for achieving reproducible and clinically useable islet isolations using this product...
- Liver transplantation in HIV-infected recipientsMichelle E Roland
Department of Medicine, Positive Health Program, AIDS Division, University of California, San Francisco, CA, USA
Semin Liver Dis 26:273-84. 2006....
- Solid organ transplantation is a reality for patients with HIV infectionMichelle E Roland
Department of Medicine, University of California, Positive Health Program AIDS Division at San Francisco General Hospital, Ward 84, Building 80, 995 Potrero Avenue, San Francisco, CA 94110, USA
Curr HIV/AIDS Rep 3:132-8. 2006..Because important patient selection and clinical management questions remain, it is critical that ongoing studies are completed quickly...
- Solid organ transplantation: referral, management, and outcomes in HIV-infected patientsMichelle E Roland
University of California, San Francisco, USA
AIDS Read 16:664-8, 675-8. 2006..Timely referral for transplant evaluation will prevent unnecessary mortality during the pre-transplant evaluation process...
- Renal transplantation in patients with HIVLynda A Frassetto
Department of Medicine and Clinical Research Center, University of California, San Francisco, CA 94143, USA
Nat Rev Nephrol 5:582-9. 2009..It also describes the clinical concerns associated with the treatment of renal transplant recipients with HIV...
- Outcome of patients with hepatitis B virus and human immunodeficiency virus infections referred for liver transplantationNorah A Terrault
Department of Medicine, University of California at San Francisco, San Francisco, CA 64143 0538, USA
Liver Transpl 12:801-7. 2006..In HIV-HBV coinfected patients undergoing LT, HBV recurrence is successfully prevented with combination prophylaxis using HBIG and antivirals...
- Review of solid-organ transplantation in HIV-infected patientsMichelle E Roland
Department of Medicine, University of California, San Francisco, California, USA
Transplantation 75:425-9. 2003
- Malignancy in the HIV-infected patients undergoing liver and kidney transplantationNicholas N Nissen
Cedars Sinai Medical Center, West Hollywood, California, USA
Curr Opin Oncol 24:517-21. 2012..The addition of transplant immunosuppressants to an already immunocompromised state, however, may increase the risk of malignancy...
- Targeted gene therapy with CD40Ig to induce long-term acceptance of liver allograftsGeorge J Chang
Division of Transplantation Surgery, Department of Surgery, University of California, San Francisco School of Medicine, 94143, USA
Surgery 132:149-56. 2002..The purpose of this study was to modulate the immune response of rat liver transplant recipients by adenovirus-mediated gene transfer of CD40Ig, a secretable fusion protein designed to block the CD40-CD154 T-cell costimulation pathway...
- The rationale for the new deceased donor pancreas allocation schemaMark D Stegall
Department of Surgery, Division of Transplantation Surgery, Mayo Clinic, Rochester, MN 55905, USA
Transplantation 83:1156-61. 2007..To ensure the continued success of whole organ pancreas and islet transplantation, deceased donor pancreas allocation policy must continue to evolve...
- Islet transplantation in type 1 diabetic patients using calcineurin inhibitor-free immunosuppressive protocols based on T-cell adhesion or costimulation blockadeAndrew M Posselt
Transplant Division, Department of Surgery, University of California, San Francisco, San Francisco, CA 94143 0790, USA
Transplantation 90:1595-601. 2010....
- Predictors associated with terminal renal function in deceased organ donors in the intensive care unitAnnabel Blasi-Ibanez
Department of Anesthesia and Perioperative Care, University of California San Francisco, California, 94143 0648, USA
Anesthesiology 110:333-41. 2009..Factors determining renal function at organ recovery in deceased kidney donors are not well established...
- Liver and kidney transplantation in HIV-infected patientsClara C Tan-Tam
Department of Surgery, University of California, San Francisco, CA, USA
AIDS Rev 11:190-204. 2009..This review examines the current clinical strategies and issues surrounding liver and kidney transplantation in HIV-infected patients...
- Key clinical, ethical, and policy issues in the evaluation of the safety and effectiveness of solid organ transplantation in HIV-infected patientsMichelle E Roland
Positive Health Program Department of Medicine University of California, San Francisco Ward 84, San Francisco General Hospital 995 Potrero Ave San Francisco, CA 94110, USA
Arch Intern Med 163:1773-8. 2003
- Successful long-term outcomes using pediatric en bloc kidneys for transplantationJade S Hiramoto
Department of Surgery, University of California San Francisco, USA
Am J Transplant 2:337-42. 2002..The objective of our study was to determine whether acceptable long-term graft survival and function can be achieved using pediatric en bloc renal transplants by employing specific immunologic and selection strategies...
- Ethical issues in split versus whole liver transplantationAnntim Vulchev
Department of Surgery, Division of Transplantation, University of California, San Francisco, San Francisco, CA, USA
Am J Transplant 4:1737-40. 2004..This essay explores the ethical issues involved in the allocation of split livers, and proposes general policy guidelines for the allocation of split versus whole liver transplants...
- Long-term survival and renal transplantation in a monozygotic twin with cloacal dysgenesis sequenceRita A Mukhtar
Department of Surgery, University of California, San Francisco, CA 94143, USA
J Pediatr Surg 44:e31-3. 2009..Pediatr Dev Pathol 1998;1:281-288). We report a case of long-term survival, currently to 25 months of age, and renal transplantation in a monochorionic, diamniotic twin girl with CDS...
- Current status of kidney and pancreas transplantation in the United States, 1994-2003Gabriel M Danovitch
David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA
Am J Transplant 5:904-15. 2005..The percentage of Hispanic/Latino recipients increased from 5% to 9% over the same period...
- Determinants of transplant surgeons' willingness to provide organs to patients infected with HBV, HCV or HIVScott D Halpern
Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, 19104 6021, USA
Am J Transplant 5:1319-25. 2005..HIV-infected patients should have equal access to organs unless or until evidence emerges that they fare substantially worse than other potential recipients...
- [Comprehensive guidelines translate research findings into clinical policy for HIV-infected transplant candidates and recipients]Michelle E Roland
Enferm Infecc Microbiol Clin 23:331-4. 2005
- Rapid deterioration of HIV co-infected patients waiting for liver transplantation is not predicted by MELDPeter G Stock
Liver Transpl 11:1315-7. 2005
- Management of lymphoceles after renal transplantation: laparoscopic versus open drainageT Florian Fuller
Department of Urology, Charite Hospital, Humboldt University Berlin, Germany
J Urol 169:2022-5. 2003..In this single center study we retrospectively reviewed our results of the surgical management of post-transplant lymphoceles, assessing indication and outcome of laparoscopic versus open drainage...
- End stage polycystic kidney disease: indications and timing of native nephrectomy relative to kidney transplantationT Florian Fuller
Department of Urology, Charite University Hospital, Campus Charite Mitte, Schumannstrasse 20 21, 10117 Berlin, Germany
J Urol 174:2284-8. 2005..We evaluated the indications for and outcome of pre-transplant, concomitant and post-transplant native nephrectomy in patients with end stage polycystic kidney disease (PCKD)...
- Solid Organ Transplantation in HIV: Multi-Site StudyPeter Stock; Fiscal Year: 2007....